» Articles » PMID: 24430596

Late-onset Right Ventricular Failure in Patients with Preoperative Small Left Ventricle After Implantation of Continuous Flow Left Ventricular Assist Device

Overview
Journal Circ J
Date 2014 Jan 17
PMID 24430596
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background:  The continuous flow (CF) left ventricular assist device (LVAD) has replaced the pulsatile flow (PF) LVAD because of its advantages of better patient survival and higher quality of life. However, "late-onset right ventricular failure (RVF)" after CF LVAD implantation has emerged as an increasing concern, but little is known about the mechanism.

Methods And Results:  We retrospectively analyzed the 3-month hemodynamic and echocardiographic data from 38 consecutive patients who had received CF LVADs, and from 22 patients who had received PF LVADs. Late-onset RVF was defined as persistent right ventricular stroke work index (RVSWI) <4.0g/m(2) at any rotation speed and after saline infusion test at 5 weeks after implantation of CF LVAD. Patients with late-onset RVF had significantly impaired exercise tolerance indicated by shorter 6-min walking distance and lower peak VO2, and worsened tricuspid regurgitation, together with enlargement of the RV under CF LVAD treatment (all P<0.05). Univariable analyses demonstrated that preoperative smaller LV diastolic diameter (LVDd) was the risk factor for late-onset RVF with a cutoff value of 64mm calculated by ROC analysis (area under curve, 0.925). In contrast, there was no correlation between preoperative LVDd and postoperative RVSWI in the PF LVAD group, though their preoperative background was worse than that of the CF group.

Conclusions:  In the setting of preoperative small LVDd, CF LVAD may cause late-onset RVF by leftward shift of the interventricular septum.  (Circ J 2014; 78: 625-633).

Citing Articles

Monitoring of the right ventricular responses to pressure overload: prognostic value and usefulness of echocardiography for clinical decision-making.

Dandel M Cardiovasc Diagn Ther. 2024; 14(1):193-222.

PMID: 38434557 PMC: 10904302. DOI: 10.21037/cdt-23-380.


A case of progressive right ventricular failure with ventricular arrhythmia and aortic insufficiency after implantable left ventricular assist device implantation.

Jimba T, Hatano M, Fujiwara T, Akazawa H, Watanabe M, Kinugawa K J Cardiol Cases. 2024; 29(1):7-10.

PMID: 38188322 PMC: 10770093. DOI: 10.1016/j.jccase.2023.08.017.


Right heart failure after left ventricular assist device implantation: a persistent problem.

Siems C, Aggarwal R, Shaffer A, John R Indian J Thorac Cardiovasc Surg. 2023; 39(Suppl 1):161-169.

PMID: 37525713 PMC: 10387018. DOI: 10.1007/s12055-023-01481-z.


Left ventricular assist device in cardiac amyloidosis: friend or foe?.

Sciaccaluga C, De Carli G, Fusi C, Stefanini A, Mandoli G, Giacomin E Heart Fail Rev. 2022; 28(2):359-365.

PMID: 36451061 DOI: 10.1007/s10741-022-10288-w.


Prognostic value of TAPSE/PASP ratio in right ventricular failure after left ventricular assist device implantation: Experience from a tertiary center.

Sert S, Selcuk N, Yildirimturk O, Orhan G Turk Gogus Kalp Damar Cerrahisi Derg. 2022; 30(3):334-343.

PMID: 36303699 PMC: 9580292. DOI: 10.5606/tgkdc.dergisi.2022.23218.